Expanding the Treatment Window for the FDA-Approved Radiation Countermeasure Nplate
Gregory P Holmes-Hampton(Uniformed Services University of the Health Sciences), Sanchita P Ghosh(Uniformed Services University of the Health Sciences), Venkateshwara Rao Dronamraju(Henry M. Jackson Foundation), Susan L. Whiteway(Uniformed Services University of the Health Sciences), Vidya P Kumar(Henry M. Jackson Foundation), Jim R Managbanag(Uniformed Services University of the Health Sciences)
Cited by 0
Related Papers
Inhibition of cyclin-dependent kinase 6 suppresses cell proliferation and enhances radiation sensitivity in medulloblastoma cells
|Journal of Neuro-Oncology|2012|67
Targetable molecular alterations in congenital glioblastoma
|Journal of Neuro-Oncology|2019|39
Healthcare providers’ promotion of physical activity among child and adolescent cancer survivors: strategies and challenges
|Journal of Cancer Survivorship|2022|13
Dysfunctional Immune System Reconstitution After Rituximab Exposure In Utero
|Journal of Pediatric Hematology/Oncology|2020|11
Tuberous sclerosis complex
|Neurology Clinical Practice|2016|9